Soros Fund Management - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 9 filers reported holding ACORDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,512,805
-11.4%
27,951,000
-0.2%
0.22%
-19.4%
Q2 2023$17,500,625
-0.2%
28,001,0000.0%0.27%
+1.1%
Q1 2023$17,535,626
-0.8%
28,001,0000.0%0.27%
+11.1%
Q4 2022$17,679,131
+9.2%
28,001,0000.0%0.24%
-12.0%
Q3 2022$16,190,000
-0.1%
28,001,0000.0%0.28%
-4.5%
Q2 2022$16,213,000
-23.4%
28,001,0000.0%0.29%
-10.2%
Q1 2022$21,167,000
-6.7%
28,001,0000.0%0.32%
+3.9%
Q4 2021$22,681,000
+0.9%
28,001,0000.0%0.31%
-25.3%
Q3 2021$22,469,000
+9.2%
28,001,0000.0%0.42%
+19.6%
Q2 2021$20,573,000
+3.5%
28,001,0000.0%0.35%
-7.0%
Q1 2021$19,881,00028,001,0000.37%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 25,875,000$15,266,2501.51%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 45,283,000$30,905,6481.28%
Saltoro Capital, LP 1,500,000$877,5000.79%
UBS OCONNOR LLC 30,000,000$19,200,0000.48%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 52,324,000$28,244,1460.45%
Soros Fund Management 27,951,000$15,512,8050.22%
D. E. Shaw & Co., Inc. 14,000,000$7,980,0000.01%
WELLS FARGO & COMPANY/MN 5,018,000$3,424,7850.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACORDA THERAPEUTICS INC shareholders